Brosnan Margaret E, Brosnan John T
Department of Biochemistry, Memorial University of Newfoundland, St John's, NL, Canada, A1B 3X9.
J Nutr. 2004 Oct;134(10 Suppl):2791S-2795S; discussion 2796S-2797S. doi: 10.1093/jn/134.10.2791S.
The kidney plays a major role in arginine metabolism in 3 principal ways: arginine synthesis, creatine synthesis, and arginine reabsorption. Appreciable quantities of arginine are synthesized in the kidney from citrulline produced by the intestine. The renal enzymes of arginine synthesis, argininosuccinate synthetase and argininosuccinate lyase, occur in the cells of the proximal tubule. The rate of arginine synthesis depends on citrulline delivery and does not appear to be regulated by dietary arginine availability. Renal arginine synthesis in humans produces approximately 2 g arginine/d, which may be compared to an intake, from a Western diet, of approximately 4 to 5 g/d. Spontaneous, nonenzymatic breakdown of creatine and creatine phosphate to creatinine causes the excretion of 1 to 2 g creatinine/d and requires the replacement of an equivalent amount of creatine from the diet and by endogenous synthesis. The first enzyme of creatine biosynthesis, L-arginine:glycine amidinotransferase, occurs in the kidney and produces guanidinoacetate, which is released into the renal vein. The renal output of guanidinoacetate, however, is rather low, and we propose that the entire pathway of creatine synthesis may also occur in the liver. Renal arginine reabsorption salvages approximately 3 g arginine/d. At the apical membrane of proximal tubular cells, arginine shares a transporter with lysine, ornithine, and cystine. Defects in this heteromeric transporter cause cystinuria, which is also characterized by urinary loss of arginine, lysine, and ornithine. Arginine is transported out of the proximal tubular cells at the basolateral membrane by another heteromeric transporter, which also transports lysine and ornithine. Defects in this transporter cause lysinuric protein intolerance.
精氨酸合成、肌酸合成和精氨酸重吸收。肠道产生的瓜氨酸在肾脏中合成了相当数量的精氨酸。精氨酸合成的肾脏酶,即精氨琥珀酸合成酶和精氨琥珀酸裂解酶,存在于近端小管细胞中。精氨酸合成的速率取决于瓜氨酸的供应,似乎不受饮食中精氨酸可用性的调节。人类肾脏精氨酸合成每天产生约2克精氨酸,与之相比,西方饮食的摄入量约为每天4至5克。肌酸和磷酸肌酸自发的非酶促分解为肌酐导致每天排泄1至2克肌酐,这需要从饮食和内源性合成中补充等量的肌酸。肌酸生物合成的第一种酶,L-精氨酸:甘氨酸脒基转移酶,存在于肾脏中并产生胍基乙酸,后者释放到肾静脉中。然而,胍基乙酸的肾脏输出相当低,我们认为肌酸合成的整个途径也可能发生在肝脏中。肾脏精氨酸重吸收每天挽救约3克精氨酸。在近端小管细胞的顶端膜,精氨酸与赖氨酸、鸟氨酸和胱氨酸共用一个转运体。这种异源转运体的缺陷会导致胱氨酸尿症,其特征还包括精氨酸、赖氨酸和鸟氨酸的尿流失。精氨酸通过另一种异源转运体从近端小管细胞的基底外侧膜运出,该转运体也运输赖氨酸和鸟氨酸。这种转运体的缺陷会导致赖氨酸尿性蛋白不耐受。